| AVUNX | VITSX | AVUNX / VITSX | |
| Total Expense Ratio | 0.00 | 0.03 | - |
| Annual Report Gross Expense Ratio | 0.15 | 0.03 | 500% |
| Fund Existence | 6 years | 29 years | - |
| Gain YTD | 17.900 | 12.872 | 139% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 719M | 2.29T | 0% |
| Annual Yield % from dividends | 1.11 | 1.06 | 105% |
| Returns for 1 year | 25.59 | 21.03 | 122% |
| Returns for 3 years | 79.10 | 74.30 | 106% |
| Returns for 5 years | 80.72 | 66.57 | 121% |
| Returns for 10 years | N/A | 249.92 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SBHIX | 29.21 | 0.28 | +0.97% |
| Saratoga Health & Biotechnology I | |||
| GQJPX | 12.86 | 0.08 | +0.63% |
| GQG Partners Intl Qual Val Fd Inv | |||
| OEGAX | 31.54 | 0.16 | +0.51% |
| Invesco Discovery Mid Cap Growth A | |||
| GRISX | 34.52 | 0.15 | +0.44% |
| Nationwide S&P 500 Index Instl Svc | |||
| TNRAX | 23.07 | 0.09 | +0.40% |
| 1290 Avantis U.S. Large Cap Growth A | |||